Barbara Leutgeb

1.2k total citations · 1 hit paper
8 papers, 674 citations indexed

About

Barbara Leutgeb is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Barbara Leutgeb has authored 8 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Barbara Leutgeb's work include Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Barbara Leutgeb is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Barbara Leutgeb collaborates with scholars based in Germany, United States and Switzerland. Barbara Leutgeb's co-authors include Angela Wirth, Erich F. Greiner, Christiane Maser‐Gluth, Petra Örsy, Günther Schütz, Martina Lukasova, Nina Wettschureck, Zoltán Benyó, Stefan Gorbey and Béla Horváth and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Journal of Investigative Dermatology.

In The Last Decade

Barbara Leutgeb

8 papers receiving 664 citations

Hit Papers

G12-G13–LARG–mediated signaling in vascular smooth muscle... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Leutgeb Germany 7 390 118 106 101 91 8 674
Frances Kern Switzerland 15 371 1.0× 129 1.1× 80 0.8× 172 1.7× 105 1.2× 20 694
Frédéric Dandré France 7 620 1.6× 67 0.6× 51 0.5× 90 0.9× 140 1.5× 8 897
Florian Alonso Switzerland 20 479 1.2× 47 0.4× 118 1.1× 94 0.9× 72 0.8× 40 855
Frederic Pipp Germany 10 718 1.8× 76 0.6× 66 0.6× 83 0.8× 158 1.7× 19 1.0k
Ulrike Seay Germany 11 389 1.0× 44 0.4× 65 0.6× 113 1.1× 116 1.3× 15 672
Anna Zanellato Italy 13 495 1.3× 116 1.0× 56 0.5× 73 0.7× 61 0.7× 19 860
Jean‐Marie Daniel Lamazière France 16 452 1.2× 69 0.6× 67 0.6× 93 0.9× 88 1.0× 22 1.0k
Angelika Kusch Germany 15 277 0.7× 52 0.4× 55 0.5× 74 0.7× 110 1.2× 24 619
Hisaki Hayashi Japan 14 557 1.4× 43 0.4× 61 0.6× 119 1.2× 115 1.3× 26 788
Young Shin Ryu South Korea 10 628 1.6× 52 0.4× 60 0.6× 80 0.8× 126 1.4× 14 869

Countries citing papers authored by Barbara Leutgeb

Since Specialization
Citations

This map shows the geographic impact of Barbara Leutgeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Leutgeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Leutgeb more than expected).

Fields of papers citing papers by Barbara Leutgeb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Leutgeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Leutgeb. The network helps show where Barbara Leutgeb may publish in the future.

Co-authorship network of co-authors of Barbara Leutgeb

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Leutgeb. A scholar is included among the top collaborators of Barbara Leutgeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Leutgeb. Barbara Leutgeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Stein, Alexander, Volker Petersen, Jörg Seraphin, et al.. (2014). Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study. Acta Oncologica. 54(2). 171–178. 12 indexed citations
3.
Herrlinger, Ulrich, Niklaus Schaefer, Joachim P. Steinbach, et al.. (2014). Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolomide in newly diagnosed, MGMT-non-methylated glioblastoma patients.. Journal of Clinical Oncology. 32(15_suppl). 2042–2042. 10 indexed citations
4.
Herrlinger, Ulrich, Niklaus Schaefer, Joachim P. Steinbach, et al.. (2013). Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial.. Journal of Clinical Oncology. 31(15_suppl). LBA2000–LBA2000. 17 indexed citations
5.
Herrlinger, Ulrich, Niklaus Schaefer, Joachim P. Steinbach, et al.. (2013). Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-nonmethylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial.. Journal of Clinical Oncology. 31(18_suppl). LBA2000–LBA2000. 8 indexed citations
6.
Wirth, Angela, Zoltán Benyó, Martina Lukasova, et al.. (2007). G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nature Medicine. 14(1). 64–68. 511 indexed citations breakdown →
7.
Zweers, Manon C., Jeffrey M. Davidson, Ambra Pozzi, et al.. (2006). Integrin α2β1 Is Required for Regulation of Murine Wound Angiogenesis but Is Dispensable for Reepithelialization. Journal of Investigative Dermatology. 127(2). 467–478. 105 indexed citations
8.
Veelken, Hendrik, Barbara Leutgeb, Peter Kulmburg, et al.. (1998). Enhancement of a constitutively active promoter for gene therapy by a positive feed-back transcriptional activator mechanism.. International Journal of Molecular Medicine. 2(4). 423–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026